-
An Innovative Graduate Program Balancing Science and Engineering: Meeting the Needs of Industry for Ph.D. Entry-level Scientists in Pharmaceutical Technology
Monday, November 12
12:00 pm – 1:15 pm
The FDA Quality by Design initiative requires a different skill set than the traditional industrial and/or physical pharmacy graduate program provides. The need for appropriately trained pharmaceutical technologists in the industry and FDA is growing. However, pharmaceutical technology graduate programs have almost disappeared from pharmaceutical science programs. The Education Committee of the National Institute of Pharmaceutical Technology and Education (NIPTE) has defined an innovative curriculum in Pharmaceutical Engineering and Science (PES) that combines the essentials of physical/industrial pharmacy with those in engineering to create an educational framework to meet the current and future needs of the industry. The balance between engineering and pharmaceutics is in the new curriculum is a key issue. This session will introduce the core curriculum and programs. The balance between traditional pharmaceutics and engineering will be the focus of an extensive discussion
Moderator
Robin Bogner, Ph.D.
University of Connecticut
Speakers
Fernando Muzzio
Rutgers University
Lee Kirsch, Ph.D.
University of Iowa
Kenneth Morris, Ph.D.
Purdue University
AAPS Graduate Student Symposium in Drug Delivery and Pharmaceutical Technologies and the PDD & PT Research Achievement Award Winners Lectures
Tuesday, November 13
8:30 am – 11:00 am
Sponsored by Bristol-Myers Squibb Company
Graduate students whose research has been competitively judged as outstanding will present findings of their research efforts. Special awards are given to the presenters at the session’s conclusion. Also, the scientists whose work have been recognized by the PDD Research Achieement Award and the PT Research Achievement will present a summary of their research efforts during this season. Attendees will have the opportunity to discuss the work and exchange ideas.
Moderators
Venkatramana Rao, Ph.D.
Bristol-Myers Squibb Company
Vishal Gupta, Ph.D.
Covidien